Caralluma Fimbriata anti kanser
Caralluma
fimbriata is a popular edible cactus from India. It grows abundantly
throughout India’s interior, even along the roadsides. It’s part of the diet of
several native Indian populations. It has been used for thousands of years in
Indian culture for helping suppress appetite during long hunts and times of
famine. It typically blooms in late summer. Its blossoms are usually brown,
purple, tan, yellow, and red. The plant can also be found throughout parts of:
·
Africa
·
Middle East
·
Southern Europe, especially the Canary Islands
Recently,
people have begun to use the extract of C.
fimbriata to help them:
·
lose weight
·
build endurance
·
suppress thirst
How do you use it?
In
India where C.
fimbriata grows, people use it in a variety of ways. Despite
its foul smell, many choose to eat it raw or simply boil it first. Others cook
it as a vegetable with spices or add it to condiments like chutneys and
pickles. In the United States, it is most often taken in extract form as a
supplement.
Is it safe for consumption?
Caralluma
fimbriata is considered safe for consumption. The U.S. Food and Drug
Administration (FDA) added it to the GRAS (generally recognized as safe) list of food ingredients in
2014.
As
an extract — the form most often used in the United States — the recommended
dosage is 500 milligrams taken up to twice daily for 60 days. Its effect on the
body when used for longer than 60 days is unknown. For this reason, long-term
use should be avoided.
You
run the risk of stomach problems if you take too much C. fimbriata. Be
sure to pay attention to the product label and limit yourself to 500 milligrams
at a time. As with any supplement, be sure to check with your doctor before
taking it.
What the research says
Research
results on the effectiveness of C.
fimbriata are mixed. Some studies say ithas little effect, and
others say that it helps reduce hunger and helps people lose weight. No studies
have showed any harmful effects from taking C. fimbriata at recommended dosages.
A
study published in the journal Perspectives
in Clinical Research concluded that more research is needed before C. fimbriata extract
can be recommended as an anti-obesity drug. No statistically significant loss
in weight or body measurements was found among obese participants of the study
who used C.
fimbriata extract for 12 weeks. However, study participants
did not experience any adverse effects from taking the extract.
On
the positive side, a review of clinical trials published in the journal Complementary
Therapies in Medicine found that Caralluma
fimbriataextract was one of only two plant extracts from 14 studies
that had measurable outcomes in reducing appetite or food intake.
Another
study published in Complementary
Therapies in Medicine concluded that C.
fimbriata supplementation has the potential to curb central
obesity when combined with dietary control and physical activity. Central
obesity is a key factor in metabolic
syndrome, which can increase the likelihood of developing heart disease,
diabetes, and stroke. In the study, 43 adults between the ages of 29 and 59
combined dietary control and physical activity with C. fimbriata supplementation.
Those in the group that took the C.
fimbriata lost a little more than 2 inches around their waists
during the study period. This was more than double the average loss of less
than 1 inch among the control group participants.
A
study published in the North American Journal of Medical Sciences found
that C. fimbriata extract
significantly helped curb compulsive overeating among children and adolescents
with Prader-Willi syndrome (PWS). This is a condition that leads to compulsive
overeating. Researchers conducted a placebo-controlled, double-blind,
randomized trial for 10 weeks with participants in Australia and New Zealand.
Everyone took either C.
fimbriata extract or a placebo for four weeks before a
two-week break. After the break, participants switched groups. Those on the
placebo took C.
fimbriata extract, and vice versa. Results showed that
the C. fimbriata helped
curb appetite, with no adverse effects at any stage of the trial.
C.
fimbriata may have other health benefits and is being researched for its
role as an anticancer agent and as an effective antioxidant.
..
No comments:
Post a Comment
Note: only a member of this blog may post a comment.